Background and Purpose-In the general population, migraine, cerebrovascular diseases, and vascular dementia differ in many aspects between men and women. CADASIL is considered a unique model to investigate migraine with aura, stroke, and dementia related to ischemic small vessel disease. This study aims to evaluate the effect of gender on the main clinical and neuroimaging characteristics of CADASIL. Methods-Cross-sectional data from 313 CADASIL patients including various clinical and cognitive scores and MRI parameters were compared between men and women, and between those younger and older than the median age of the population corresponding to the usual age of menopause (51 years). Results-At younger than 51 years, migraine with aura was 50% more prevalent in women and stroke was 75% more prevalent in men. After the fifth decade, men had higher National Institutes of Health Stroke Scale and Rankin scores than women and more severe executive dysfunction, although global cognitive scores were similar. Age at first stroke, the number of stroke events, and the prevalence of dementia and psychiatric symptoms did not differ between men and women. Brain volume was lower in men with a trend for a larger volume of lacunar infarcts. Conclusions-In CADASIL, migraine with aura is more frequent in women and stroke is more frequent in men before the age of menopause. This difference seems to vanish after this age limit but may result in a higher degree of cognitive impairment and cerebral atrophy in men at the late stage of the disease. The presumable role of ovarian hormones in these gender-related differences remains to be explored. (Stroke. 2012;43:137-141.)
I
n the general population, migraine, cerebrovascular diseases, and vascular dementia differ in many aspects between men and women. The prevalence of migraine appears to be 3-to 4-times higher in women than in men. [1] [2] [3] In women, migraine is further influenced by the different stages of the reproductive life (menarche, pregnancy, menopause) or by the exposure to exogenous sex hormones such as contraception. 4 In contrast, the age-adjusted prevalence and incidence of stroke are, respectively, 30% and 40% higher in men than in women. 5 A similar trend for male gender is observed for the prevalence and incidence of vascular dementia. 6, 7 Accumulating evidence suggests that these differences may be related to female hormones that can both modify the excitability of the cortex 8, 9 and exert major neuroprotective effects. 10, 11 CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is a hereditary small vessel disease of the brain caused by mutations of the Notch3 gene on chromosome 19. 12 The disease is characterized by the occurrence of migraine with aura, subcortical ischemic stroke, and psychiatric symptoms, and it leads progressively to disability and dementia. 13 CADASIL is considered a model of "pure" subcortical ischemic vascular dementia and a typical cause of secondary migraine with aura of vascular origin. Although some differences were previously reported between men and women in CADASIL, 14 the exact role of gender on the phenotype of the disorder has not been specifically investigated. In the present study, we evaluated the gender effect on the clinical and neuroimaging manifestations of CADASIL in a large cohort of patients.
Subjects and Methods

Subjects
A total of 313 CADASIL patients having a typical mutation of the Notch3 gene were included in the study. They were recruited from a large prospective cohort of patients investigated at Lariboisière Hospital in Paris (nϭ191) and at the Ludwig Maximilians University Neurology Clinic in Munich (nϭ122). The study was approved by an independent ethics committee at both centers. All patients gave a written informed consent to participate.
Clinical Evaluation
All subjects underwent a detailed neurological examination during the 2 hours preceding MRI examination, including a Mini-Mental State Examination, Mattis Dementia Rating Scale, and modified Rankin scale. Clinical and demographic data were collected, including age, sex, cardiovascular risk factors including hypertension (defined as diagnosis of hypertension or using antihypertensive drugs), diabetes (1997 World Health Organization criteria), hypercholesterolemia (diagnosis of hypercholesterolemia or using lipidlowering drugs), smoking habits and alcohol intake, history of migraine with aura (MA; International Headache Society diagnostic criteria), stroke, transient ischemic attack, psychiatric symptoms including depression, apathy (based on Neuropsychiatric Inventory assessment applied to 132 patients only), seizures, gait and balance problems, hearing loss, urinary incontinence, and presence of dementia (Diagnostic and Statistical Manual of Mental Health Disorder IV criteria).
MRI
The imaging protocol already has been detailed previously. 15 Briefly, MRI was performed on a 1.5-T system (Vision [Siemens] or Signa [General Electric Medical Systems]). Three-dimensional and millimetric T1-weighted MRI and fluid-attenuated inversion recovery, T2*-weighted gradient echo, proton density, and diffusion-weighted images of 5-mm thickness were obtained over the entire brain in axial planes. Diffusion data were not used in the present analysis.
Image Processing and Analysis
Image processing and analysis have been previously reported by Viswanathan et al. 16 A dedicated software (Brainvisa) was used to determine the global brain volume from T1-weighted MR images after exclusion of cerebral spinal fluid containing voxels in addition to the volume of the intracranial cavity assessed on proton density images. Brain parenchymal fraction was defined as the ratio of total brain tissue volume to the total intracranial cavity volume: brain parenchymal fraction ϭ (brain tissue volume/intracranial cavity volume) ϫ100. The volume of white matter hyperintensities was obtained on fluid-attenuated inversion recovery images of lacunar lesions on T1 scans. The total volume of white matter hyperintensities and that of lacunes were normalized to the intracranial cavity in each patient: normalized volume ϭ (total volume/intracranial cavity volume) ϫ100. The number of microbleeds on T2* sequences was also recorded in each patient.
Statistical Methods
To investigate the relationship between clinical manifestations, cognitive scores, and MRI parameters between men and women, we used the Student t tests or Wilcoxon tests for categorical variables and analysis of covariance for continuous variables. The comparison between men and women was performed after adjustments for age, history of cardiovascular disease, hypertension, diabetes, and education level according to the parameter undergoing investigation. Comparisons were also made between women and men older than or younger than the median age of the population (which corresponds approximately to the usual age of menopause) to investigate a potential hormonal influence. PՅ0.05 was considered statistically significant.
Results
The clinical and MRI data from 313 patients (172 women and 141 men) whose mean age was 51Ϯ11.4 years (women, 50.4Ϯ12.2 years; men, 51.8Ϯ10.3 years) were analyzed. No significant difference was detected for the main cardiovascular risk factors: hypertension (22.6% in men versus 19.8% in women), diabetes (3.1% versus 1.5%), hypercholesterolemia (40.3% versus 43.0%), current smoking (25.2% versus 19.4%), and for any cardiovascular risk factor (79.7% versus 87.2%), with the exception of alcohol consumption (men, 79.1%; women, 49.7%; PϽ0.001).
The frequency of the main clinical manifestations of the disorder according to gender are presented in Tables 1 and 2 . The prevalence of MA was higher in women than in men. This female predominance was significant only in subjects younger than 51 years of age. Conversely, stroke events were more prevalent in men. This difference was also significant only in subjects aged younger than 51 years.
In contrast the prevalence of transient ischemic attack, age at first stroke and number of stroke events did not differ according to gender. We found no significant difference between men and women in the prevalence of dementia, psychiatric symptoms including depression, seizures, gait and balance problems, hearing loss, and urinary incontinence. In contrast, apathy was found to be twice as prevalent in the male group, a difference significant both before and after 51 years.
The characteristics of MA in the 2 groups are presented in Table 3 . In women, MA started at an earlier age (younger than 30 years in the majority of migraineurs) than in men. More women than men experienced visual and aphasic auras. The prevalence of sensory and motor auras as well as the frequency of migraine episodes, duration of aura and of headache, and presence of triggering factors did not differ according to gender.
The comparison of baseline clinical scores between women and men is summarized in Table 4 . Men were found to be more disabled than women with higher Rankin and National Institutes of Health Stroke Scale scores. There was no significant difference in global scores of cognitive performances (Mini-Mental State Examination, Mattis), but men did worse on Mattis initiation test mainly evaluating executive functions. These differences were significant only in subjects older than 51 years of age.
The comparison of MRI parameters according to gender is summarized in Tables 5 and 6 . The brain parenchymal fraction was significantly lower in men, suggesting higher brain atrophy in men compared to women. This finding was observed independently of age stratification. The volume of lacunar infarcts was 50% larger in men than in women, but this difference did not reach statistical significance, although the mean difference was 75% in subjects younger than 51 years. In contrast, the volume of white matter hyperintensities and number of microbleeds did not differ between men and women.
Discussion
There are 2 main findings in this large sample of CADASIL patients. First, before the usual age of menopause, MA appears to be more prevalent and stroke appears to be less prevalent in women than in men, and this difference vanishes after the fifth decade. Second, in the whole population, men present with more apathy and a higher degree of cerebral atrophy, with a trend for a larger volume of subcortical infarcts. Moreover, after the fifth decade, men have more executive dysfunction and disability than women. The larger prevalence of MA in CADASIL women is in line with data obtained in the general population showing a nearly 2-fold excess of MA in women compared to men. [1] [2] [3] 17 MA has been associated with high levels of circulating estrogen in women. 18 In animal models, ovarian hormones were also previously shown to increase cortical excitability that promotes spreading depression, most likely responsible for the aura symptoms in humans. 9,19 -22 Experimental data recently showed that the susceptibility to cortical spreading depression is actually increased in CADASIL transgenic mice. 23 In the present study, the differences in prevalence and presentation of aura symptoms according to gender suggest that the hormonal status may further modulate this susceptibility in CADASIL patients.
The results also showed a significant male predominance of stroke prevalence in CADASIL patients in accordance with epidemiological data showing a 45% to 55% ageadjusted male excess of ischemic stroke in the general population. 5, 24 This difference has been related to protective effects of estrogens in women that can increase cerebral blood flow and vasoreactivity and show antiinflammatory, antioxidant, and antiapoptotic properties in both animal models and human studies. 10, 11, 25, 26 The observation of a significant difference only before the usual age of menopause in the CADASIL population is in agreement with this hormonal hypothesis. Interestingly, in the present cohort, age at first stroke did not differ between men and women as previously reported in a smaller study. 14 This is in contrast with the 4-years younger age at first ischemic stroke reported in men in the general population. 5, 27 The limited size of the sample may prevent the detection of such a small difference in CADASIL patients. However, together with the lack of difference in the number of stroke events, these data may also indicate that female individuals are at lower risk for stroke and that the history of ischemic events does not actually differ between men and women once the first stroke event has occurred. The lack of difference in the prevalence of transient ischemic attacks between men and women contrasts with the gender effect observed for completed stroke. The information collected during the study about transient ischemic attacks are, however, more prone to biases. Particularly, isolated auras frequently reported in CADASIL patients can be misdiagnosed as transient ischemic attacks and vice versa. Elsewhere, recall biases are presumably more frequent for transient clinical manifestations than for stroke events, particularly in the presence of cognitive impairment.
Finally, we observed that men had lower scores in tests of executive functions and presented with more severe disability during the course of the disease. These results are only significant after 51 years of age, ie, after several decades of accumulation of subcortical ischemic lesions. These results are in line with the large male predominance in apathy-a common symptom in CADASIL-already reported in a subgroup of the present cohort. 28 Although some psychological differences between men and women may partly explain this difference, recent data suggest that apathy mainly results from the accumulation of subcortical ischemic lesions leading to regional frontal cortical atrophy in CADASIL. 29 Accumulating evidence suggests that cerebral atrophy, the key marker of clinical severity in CADASIL, is related to the amount of subcortical ischemic lesion. 15 In the present study, the difference in clinical severity according to gender may be related to the more severe cerebral atrophy, with a trend for a larger volume of lacunar infarcts in men compared to women. Interestingly, in this large cohort, the difference in cerebral atrophy was detected even before the fifth decade. The difference in vascular risk factors between sexes with only a small excess in alcohol intake in men is unlikely to be responsible for this difference. The neuroprotective role of female hormones may be involved in this gender-related difference. There are a number of limitations in the present study. No validated measure of menopausal status was used and age at menopause was not actually assessed at the individual level in the present study. The age limit of 51 years chosen for stratified analysis was only based on the median value of age in the studied population that corresponds to the usual age at menopause in the general population. However, there are no data suggesting that the reproductive life differs in CADASIL patients from that observed in the general population. We also cannot exclude some biases in the collection of clinical data, such as recall biases in the older subjects or in the presence of cognitive impairment or related to difficulties in discriminating migrainous auras from transient ischemic attacks. The data were cross-sectional and the differences observed between men and women will need further confirmation in prospective longitudinal studies. Finally, the hypothesis of a protective role of ovarian hormones was not based on hormonal evaluation in the present study. In particular, our data in no way indicate that hormone replacement therapy would be useful for stroke prevention in CADASIL because such a treatment was found to be detrimental in 2 large, randomized, controlled trials. 30, 31 The strengths of the study include the homogeneity of the population, the identical clinical and MRI protocol used in the 2 centers, and the large population evaluated by trained physicians with expertise in both stroke and migraine.
Conclusions
In conclusion, the present results strongly support that gender largely influences the clinical and MRI phenotype of CADASIL. As observed in the general population, we found that women present more MA than men and less severe disability during the course of the disease. This difference that may be related to the protective role of ovarian hormones would need confirmation in prospective studies and specific biological assessments.
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